GNH USA

Europe — EMA

Morfinesulfaat Retard Teva (Morphine Sulfate Pentahydrate)

GNH USA supplies Morfinesulfaat Retard Teva (Morphine sulfate), a opioid analgesic for severe acute pain, chronic cancer pain and chronic non‑cancer pain.

Morphine Sulfate Pentahydrate

Request sourcing

1
Pack/s

What is Morphine Sulfate Pentahydrate?

Morphine sulfate pentahydrate, the active ingredient in Morfinesulfaat Retard Teva, is an opioid analgesic presented as a prolonged‑release oral formulation for oral use. It is employed to manage severe acute pain, chronic cancer pain and chronic non‑cancer pain in adult patients. GNH USA supplies Morfinesulfaat Retard Teva as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

What is Morphine Sulfate Pentahydrate used for?

Morfinesulfaat Retard Teva is an opioid analgesic used to treat pain conditions that involve the mu‑opioid receptor pathway. - Severe acute pain: provides potent analgesia for intense postoperative or trauma‑related pain. - Chronic cancer pain: helps control persistent pain associated with malignant disease. - Chronic non‑cancer pain: offers long‑lasting relief for conditions such as severe osteoarthritis or neuropathic pain.

What are the side effects of Morphine Sulfate Pentahydrate?

Common side effects are typically dose‑related and may affect tolerability.

Common Side Effects: - Constipation: reduced gastrointestinal motility. - Nausea: upset stomach and possible vomiting. - Drowsiness: sedation and reduced alertness. - Dizziness: light‑headed sensation, especially on standing. - Dry mouth: decreased salivation. - Sweating: excessive perspiration.

Serious or Rare Side Effects: - Respiratory depression: slowed or shallow breathing that can be life‑threatening. - Severe hypotension: marked drop in blood pressure. - Anaphylactic reaction: sudden, severe allergic response. - Adrenal insufficiency: impaired cortisol production. - Serotonin syndrome: when combined with serotonergic agents, causing agitation, hyperthermia, and neuromuscular abnormalities.

What precautions apply to Morphine Sulfate Pentahydrate?

Before initiating therapy, clinicians should evaluate patient‑specific factors and monitor for adverse outcomes. - Assess pain severity: ensure opioid therapy is appropriate for the level of pain. - Monitor respiratory function: watch for signs of depression, especially after dose changes. - Evaluate for opioid dependence: screen for history of substance use disorder. - Adjust dose in renal/hepatic impairment: reduced clearance may increase toxicity risk. - Avoid concomitant CNS depressants: limit additive sedation or respiratory effects. - Store at ambient temperature: keep in the original container, protect from moisture and direct sunlight.

What does Morphine Sulfate Pentahydrate interact with?

Morphine may interact with several drug classes, altering its safety or efficacy.

Major Interactions (Avoid): - Benzodiazepines or other CNS depressants: can cause profound sedation and respiratory depression. - Monoamine oxidase inhibitors (MAOIs): increase risk of serotonin syndrome. - Respiratory depressants (e.g., barbiturates): potentiate respiratory suppression.

Moderate Interactions (Monitor Closely):\n- CYP3A4 inhibitors (e.g., ketoconazole, erythromycin): may raise morphine plasma levels. - Diuretics: can enhance hypotensive effects. - Antihistamines: may increase sedation. - Antidepressants (SSRIs, SNRIs): monitor for additive serotonergic effects.

Frequently asked questions

What is Morfinesulfaat Retard Teva used for?+
Morfinesulfaat Retard Teva contains morphine sulfate pentahydrate and is prescribed to manage severe acute pain, chronic cancer‑related pain, and chronic non‑cancer pain. It provides long‑acting analgesia through oral administration, helping patients achieve better pain control when other treatments are insufficient.
How does morphine sulfate work in the body?+
Morphine sulfate acts as a full agonist at mu‑opioid receptors in the central nervous system. By binding these receptors, it inhibits neuronal firing, reduces the release of excitatory neurotransmitters, and diminishes the perception of pain, resulting in effective analgesia.
What is the usual dose of Morfinesulfaat Retard Teva?+
The specific dose of Morfinesulfaat Retard Teva is determined by the prescribing clinician based on the individual’s pain severity, prior opioid exposure, renal and hepatic function, and other clinical factors. Patients should follow the prescriber’s instructions and not adjust the dose on their own.
Is Morfinesulfaat Retard Teva safe during pregnancy or breastfeeding?+
Safety of morphine‑containing products during pregnancy or lactation is not fully established. Use is generally reserved for situations where the benefit outweighs potential risks to the fetus or infant. Healthcare providers should evaluate each case carefully and discuss alternatives when possible.
How do I order Morfinesulfaat Retard Teva from GNH USA?+
To place an order, submit an enquiry on the product page at gnh-usa.com, specifying the required quantity. GNH USA works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.
How does Morfinesulfaat Retard Teva compare with other opioid analgesics?+
Morfinesulfaat Retard Teva offers a prolonged‑release oral formulation of morphine, providing steady plasma concentrations over an extended period. Compared with immediate‑release opioids, it reduces dosing frequency but requires careful titration and monitoring. Its efficacy is comparable to other strong opioids such as oxycodone or fentanyl when used appropriately.
What are the storage requirements for Morfinesulfaat Retard Teva?+
Store the product at ambient temperature, preferably below 25 °C. Keep it in the original packaging, protect it from moisture, heat and direct sunlight, and ensure the container is tightly closed to maintain product stability.
How is Morfinesulfaat Retard Teva administered?+
Morfinesulfaat Retard Teva is taken orally, usually as whole tablets or capsules, without crushing or chewing, to preserve the extended‑release matrix. It should be swallowed with a full glass of water, and dosing intervals are set by the prescriber.
What are the most serious risks associated with Morfinesulfaat Retard Teva?+
The most serious risks include respiratory depression, severe hypotension, profound sedation, and the potential for dependence or misuse. Patients should be monitored closely for signs of respiratory compromise, especially after dose initiation or escalation.
Who should not use Morfinesulfaat Retard Teva?+
Morfinesulfaat Retard Teva is contraindicated in individuals with known hypersensitivity to morphine or any component of the formulation, those who have experienced severe respiratory depression, acute or severe asthma, or paralytic ileus. Caution is also advised for patients with significant renal or hepatic impairment.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.
Send a sourcing enquiry for this product →

Product details

Drug
Morphine Sulfate Pentahydrate
Route
Oral Use
Manufacturer
Teva Nederland B.V.
Origin
EU

Related products

Contalgin

Contalgin

Morphine Sulfate Pentahydrate

Mundipharma A/S
EU
Dolcontin

Dolcontin

Morphine Sulfate Pentahydrate

Mundipharma As
EU
Dolcontin

Dolcontin

Morphine Sulfate Pentahydrate

Mundipharma Ab
EU
Morfin

Morfin

Morphine Sulfate Pentahydrate

Orifarm Healthcare A/S
EU